Publicacións (50) Publicacións nas que participase algún/ha investigador/a

2014

  1. A Polymorphism in the Promoter Region of the Survivin Gene is Related to Hemorrhagic Transformation in Patients with Acute Ischemic Stroke

    NeuroMolecular Medicine, Vol. 16, Núm. 4, pp. 856-861

  2. Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: Challenges and lessons learned

    American Journal of Hypertension, Vol. 27, Núm. 8, pp. 1052-1060

  3. Aging-related dysregulation of dopamine and angiotensin receptor interaction

    Neurobiology of Aging, Vol. 35, Núm. 7, pp. 1726-1738

  4. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

    Experimental Neurology, Vol. 261, pp. 720-732

  5. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?

    Neurologia, Vol. 29, Núm. 7, pp. 387-396

  6. Ataxia y nistagmo de origen infrecuente

    Revista Clinica Espanola, Vol. 214, Núm. 3

  7. Biomechanical studies: Science (f)or common sense?

    Injury, Vol. 45, Núm. 12, pp. 2035-2039

  8. Brain renin-angiotensin system and dopaminergic cell vulnerability

    Frontiers in Neuroanatomy, Vol. 8, Núm. JULY

  9. Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?

    Neurosurgical Review, Vol. 37, Núm. 4, pp. 661-668

  10. Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways

    Neuroscience, Vol. 268, pp. 48-65

  11. Demencia de inicio agudo

    Cadernos de atención primaria, Vol. 20, Núm. 4, pp. 247-248

  12. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA

    Neuropharmacology, Vol. 76, Núm. PART A, pp. 156-168

  13. Errors in recognition and management are still frequent in patients with cluster headache

    European Neurology, Vol. 72, pp. 209-212

  14. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study

    Epilepsy and Behavior, Vol. 36, pp. 144-152

  15. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study

    Cerebrovascular Diseases, Vol. 38, Núm. 5, pp. 328-336

  16. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

  17. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  18. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death

    Neuropharmacology, Vol. 85, pp. 1-8

  19. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes

    Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2657.e13-2657.e19

  20. Is posturography able to identify fallers in patients with Parkinson's disease?

    Gait and Posture, Vol. 40, Núm. 1, pp. 53-57